N.O. grants top $82,000; 16 get awards for cancer research

              The Greater New Orleans Cancer Association Inc., today announced the awarding of grants totaling $82,175.27 to 16 research scientists in the New Orleans Area,
All the grants went the field of cancer in- * vestigation.
Receiving the grants were:
Dr. Philip Pizzolato, assistant chief of laboratory service at Veterans Administration hospital, clinical assistant professor of pathology at Louisiana State university medical school, and senior consultant in pathology at Charity hospital, $5779.
DR. KENNETH H. SHULL,
assistant   professor   of   biochemistry at Tulane  university medical school, $5834. Dr. Floyd Reginald Skelton.
associate professor of pathology at Louisiana State university medical school and director of the Urban Maes Research Foundation and Laboratory, $7981. Dr.   Edward  T.  Krementz,
associate professor of surgery and cancer teaching co-ordin-ator at Tulane university and chairman of the board of directors of the Charity hospital tumor registry, $5,229.13.
Dr. William G. Thurman, instructor in pediatrics, Tulane medical school; visiting physician at Charity hospital; and consultant in pediatrics and hematology, O c h s n e r Foundation, Touro infirmary, Baptist hospital in New Orleans, and Huey P. Long hospital in Pineville and Lallie Kemp hospital in Independence, $8740.50.
DR   W.  J.  STUCKEY JR.,
assistant professor of medicine, division of hematology, Tulane medical school, $6131. ^ Dr. Keith Reemtsma, assistant professor of surgery at Tulane medical school, $4359. Dr. Neis^nJDJgpJniquist as-
sistant professor oTjSlEology at LSU medical school, $8049.
Dr. IMjarion A, GuiyWj assistant professor of biochemistry and pathology at LSU medical school, $7719.
Gerald ^F. Burns, sophomore premedical student at Loyola university, $1000.
ROBERT   WEI^AECHER,
sophomcTe^n^uIsiana Sfate university medical school, $230.
Dr. Samuel B. Nadler, professor of clinical medicine at Tulane medical school, chief investigator in the Touro Infirmary biochemistry research laboratories, senior physician at Touro, $7877.50.'
Dr. Robert F. Ryan, assistant professor of surgery at Tulane medical school, $2673.
Dr. Jose ^^ri2^520^e-s» *n" structoF Tfi^noBsTenic^ and gynecology at LSU medical school, $2993.46.
Dr. W. M. Reams Jr., assistant professor of zoology at
LSU medical school, $1518.50. Dr. Joseph C. Arcos, associate professor of medicine and biochemistry at Tulane medical school, $6059.70.
DR. PIZZOLATO'S research project involves giving a new drug, flouorouracil, to rats with cirrhosis and cancer to observe if there are any beneficial effects. If results are encouraging, the drug will be tried on patients with primary cancer of the liver.
Dr. Shull will use chemical compounds to produce cancer of the liver in rats, arid studies will be carried out in an attempt to discover the changes in cellular biology and chemistry that preceed the actual appearance of the cancer.
Dr. Skelton will attempt to develop a method of producing cancer of the adrenal glands under controlled coii^ ditions, and to study characteristics of cells as they become cancerous, and at the same time see if there is a change in the nature and/or amount of hormones produced by these cells.
Dr. Ryan will study the con> bined effects of cholcimide and nitrogen mustard on a specific type of tumor.
DR. TORRES will evaluate the sensitization response and radiation response of patients with cancer of the cervix.
Dr. Reams will attempt to discover what becomes of potential pigment cells found in a strain of mice throughout much of the connective tissues.
Since only a small number of the cells ultimately produce pigment granules, Dr. Reams will attempt to find out whether they actually become connective tissue cells, or whether they remain as latent pig-
DR. KREMENTZ will attempt to discover if, under carefully controlled experimental conditions, the increased use of oxygen potentiates the effect of cancericidal drugs on transplanted tumors in animals.
Dr. Thurman's project will involve studies of various family groups in this geographical area that are known to have unusual blood patterns. He will investigate the actual occurrence of malignant diseases in family groups that have these unusual patterns in several members of the family, and the possible causes for the decreased frequency of cancer in these people.
Dr. Stuckey's project is concerned with the production of blood cells by the bone marrow of patients with cancer who are treated with X-irradiation. He will evaluate the bone marrow function of individuals with cancer before and after treatment.
Dr. Reemtsma will work on
ment cells which may later appear as a tumor or melanoma.
Dr. Arcos, working with Dr. Mary F. Argus, will attempt
a new method of administering drugs to patients with cancer of the lungs. The method allows a higher concentration of the drug to reach the area of the tumor than can be accomplished when the drug is taken by mouth or administered intravenously. *   #   *
DR. HOLiVIQUIST will evaluate the effects of several drugs on a malignant growth of white blood cells in the mouse, and the development of resistance to the drugs by tumor cells. An attempt will be made to evaluate the effect of this type tumor on cells of the body concerned with defense against infection.
Dr. Guidry will investigate the chemical compounds to which the female sex hormones are changed by the body tissues. These hormones, and the compounds to which they are changed, will be further studied in an attempt to learn the mechanism by which they control various tissue grov^ths and processes.
Dr. Nadler will investigate the mode of action of certain antitumor agents with specific reference to the antimetabo-lites thioquanine and thioade-nine.
to discover what changes are produced by cancer-causing substances at the level of the molecule, the tiny building blocks which make up living cells.
Weilbaecher will attempt to further subfractionate an enzyme found in the blood, in abnormal amounts in certain bone diseases.
Burns will study the role that the lymphatic vessels of the gall bladder play in the concentration of bile in the gallbladder.